Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

72.91
Delayed Data
As of May 23
 +1.71 / +2.40%
Today’s Change
65.47
Today|||52-Week Range
111.00
-12.40%
Year-to-Date
PRGO Regular Dividend: PRGO will begin trading ex-dividend today with a $0.16 dividend payable to shareholders of record as of 05/26/17.
Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs
May 23 / TheStreet.com - Paid Partner Content
Investors keep calm; Trump's budget; Take-Two tumbles
May 23 / CNNMoney.com
Here's a Case Where You Might Want to Get Naked
May 23 / TheStreet.com - Paid Partner Content
David Einhorn Comments on Perrigo
May 17 / GuruFocus News - Paid Partner Content
Beware of Selling Naked Puts (Part Deux)
May 23 / TheStreet.com - Paid Partner Content
David Einhorn's Greenlight Capital First-Quarter Commentary 2017
May 17 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close71.36
Today’s open70.06
Day’s range69.96 - 73.35
Volume2,812,278
Average volume (3 months)1,955,162
Market cap$10.2B
Dividend yield0.88%
Data as of 05/23/2017

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+2.90%
Revenue growth (last year)+36.36%
P/E ratio15.4
Price/Sales3.82
Price/Book1.02

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc+0.16+0.24%
JAZZJazz Pharmaceuticals...-1.36-0.89%
ALKSAlkermes Plc-0.61-1.05%
TSROTESARO Inc+0.70+0.45%
Data as of 05/23/2017

Financials

Last reporting dateMay 24, 2017
EPS forecast (this quarter)$0.98
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
John T. Hendrickson
Chief Financial Officer
Ron L. Winowiecki
Corporate headquarters
Dublin, Dublin

Forecasts